Hemofarm Marks 59 Years of Successful Operation

This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.

We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.

Terms of use
Privacy Notice

Settings

System cookies (required)

This cookie is used for system purposes only and does not track user actions. It is required for normal functioning of this web site.

Google Analytics

This is a web analytics service.

Processing company

Google Ireland Limited
Google Building Gordon House, 4 Barrow St, Dublin, D04 E5W5, Ireland

Data Purposes

Marketing
Advertisement
Web Analytics

Technologies Used

Cookies
Pixel Tags

Data Attributes

IP address (anonymised)
Browser information (browser type, referring/exit pages, the files viewed on our site, operating system, date/time stamp, and/or clickstream data)
Usage Data (views, clicks)

Data Collected

This list represents all (personal) data that is collected by or through the use of this service.

IP address
Date and time of visit
Usage data
Click path
App updates
Browser information
Device information
JavaScript support
Pages visited
Referrer URL
Downloads
Flash version
Location information
Purchase activity
Widget interactions

Legal Basis

In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
Art. 6 (1) (a) GDPR

Location of Processing

Republic of Serbia

Retention Period

The data will be deleted as soon as they are no longer needed for the processing purposes.

Data Recipients

Alphabet Inc.

Facebook Pixel

This is a Tracking technology offered by Facebook and used by other Facebook services such as Facebook Custom Audiences.

Processing company

Facebook Ireland Limited
4 Grand Canal Square, Grand Canal Harbour, Dublin, D02, Ireland

Data Purposes

advertising
Marketing
Retargeting
Analyse
Tracking

Technologies Used

Data Attributes

Pixel specific data
Http-Header
Optional Parameters

Data Collected

This list represents all (personal) data that is collected by or through the use of this service.

Facebook user ID
Browser information
Usage data
Geräteinformationen
Non-sensitive custom data
Referrer URL
Pixel ID
Location information
Pixel specific data
User behaviour
Ads viewed
Interactions with advertisement, services, and products
Marketing information
Content viewed
IP address

Legal Basis

In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
Art. 6 para. 1 s. 1 lit. a GDPR

Location of Processing

Republic of Serbia

Retention Period

The data will be deleted as soon as they are no longer needed for the processing purposes.

Data Recipients

Facebook Inc.

Zoom Analytics

This is a web analytics service.

Processing company

Zoom Analytics Ltd.
Petah Tikva, Israel

Data Purposes

Marketing
Advertisement
Web Analytics

Technologies Used

Cookies
Pixel Tags

Data Attributes

IP address (anonymised)
Browser information (browser type, referring/exit pages, the files viewed on our site, operating system, date/time stamp, and/or clickstream data)
Usage Data (views, clicks)

Data Collected

This list represents all (personal) data that is collected by or through the use of this service.

IP address
Date and time of visit
Usage data
Click path
App updates
Browser information
Device information
JavaScript support
Pages visited
Referrer URL
Downloads
Flash version
Location information
Purchase activity
Widget interactions

Legal Basis

In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
Art. 6 (1) (a) GDPR

Location of Processing

Republic of Serbia

Retention Period

The data will be deleted as soon as they are no longer needed for the processing purposes.

Data Recipients

Alphabet Inc.

ENG

SRB

DEU

Home

About us

▾

Representative offices

Production

Our history

Business

▾

General conditions of business operations

Products

▾

Prescription drugs

Over-the-Counter Drugs

Medical devices

Dietary supplements

Consumer goods

Report adverse drug reactions

Responsibility

▾

Compliance

Social responsibility

Sustainable development

Career

▾

Corporate culture

Education of employees

Your career

Media

Blog

Contact

Hemofarm Marks 59 Years of Successful Operation

31. May 2019.

RECORD-BREAKING PRODUCTION ACCOMPANIED BY RECORD-BREAKING SALES

The leader in the pharmaceutical market of Serbia and the region and one of the largest exporters in Serbia, Hemofarm marked 59 years of successful operations. Hemofarm finished the previous year with a record-breaking output of 5.6 billion tablets when it also achieved record-breaking sales, it was pointed out at the traditional reception for employees, jubilarians, and pensioners in Vršac-based factory.

Hemofarm's success in Serbia is accompanied by results of factories in Bosnia and Herzegovina and Montenegro: Banja Luka-based Hemofarm is still a leader in B&H with a sales growth of 18%, while Podgorica-based Hemofarm achieved record-breaking production output in the past year. There were 318 people employed with Hemofarm Group in the last 12 months, i.e. between the two Company anniversaries.

State-of-the-art Hemofarm plants are in compliance with the highest international pharmaceutical standards and, with the high professionalism of staff, this company has become a guarantor of medicinal product quality for numerous European countries. As a result, over the past 10 years, production of more than 230 medicinal products has been transferred from European Union factories to Hemofarm production plants. According to the CEO of Hemofarm, Dr. Ronald Seeliger, it is precisely such company's willingness to adapt to the global market requirements, which is one of the main reasons for its success.

’Hemofarm, for example, has been prepared to implement the EU Falsified Medicines Directive (FMD) even before the deadline, which has been mandatory for all entities in the pharmaceutical supply chain as of February 9th this year. Without full implementation of this directive, we would not be able to export medicinal products to the European Union market, and Hemofarm has been delivering medicines in accordance with the new EU regulations, prior to the set deadline, i.e. since the beginning of the year’, - Dr. Seeliger pointed out on the occasion of Company Day.

According to him, every result is important for Hemofarm. ’Production and sales volume is the main indicator of success of each company, and we are proud of each individual result: the success that our medicinal product or preparation achieves in the market, the digitization process in our laboratories, the fact that many students have been employed in Hemofarm upon completion of studies. Each of these factors participates in the construction of company’s overall success’.

A great jubilee ahead of us

’We've gone a long way since the first product came out of our production lines 59 years ago. Now we are entering the great jubilee - the 60th year of operations. We have prepared many novelties for the upcoming period, with a clear intention to celebrate the past, and to look forward to the future’, Dr. Ronald Seeliger, Hemofarm’s CEO, said.